Cargando…

Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease

Management of hyperphosphatemia in patients with dialysis-dependent chronic kidney disease remains a major challenge, requiring a multifaceted approach that includes dietary phosphate restriction, dialysis, and phosphate binders. However, these treatments fail to meet serum phosphate targets in many...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fouque, Denis, Vervloet, Marc, Ketteler, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Leading Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132443/ https://www.ncbi.nlm.nih.gov/pubmed/30022383 http://dx.doi.org/10.1007/s40265-018-0950-2

Ejemplares similares

Hyperphosphatemia: The hidden killer in chronic kidney disease
por: Askar, Akram M.
Publicado: (2015)

Hyperphosphatemia Management in Patients with Chronic Kidney Disease
por: Shaman, Ahmed M., et al.
Publicado: (2016)

Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches
por: Anand, Ajeeta, et al.
Publicado: (2023)

Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity
por: Fang, Xin, et al.
Publicado: (2020)

Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease
por: Milder, Tamara Y., et al.
Publicado: (2020)

The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients
por: Shigematsu, Takashi, et al.
Publicado: (2012)

Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence
por: Coyne, Daniel W., et al.
Publicado: (2022)

Targeting NaPi-IIb for Hyperphosphatemia in Chronic Kidney Disease Patients - The Dead End?
por: Apetrii, Mugurel, et al.
Publicado: (2021)

Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology
por: Wei, Lai, et al.
Publicado: (2021)

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
por: Savica, Vincenzo, et al.
Publicado: (2008)

Functional gastrointestinal disorders among healthcare professionals at a tertiary Australian hospital
por: Nagarethinam, Meena, et al.
Publicado: (2023)

Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions
por: Bauer, Sebastian, et al.
Publicado: (2015)

Phosphate intake, hyperphosphatemia, and kidney function
por: Rubio-Aliaga, Isabel, et al.
Publicado: (2022)

Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
por: Pérez-Jeldres, Tamara, et al.
Publicado: (2021)

Hyperphosphatemia and Cardiovascular Disease
por: Zhou, Chao, et al.
Publicado: (2021)

Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
por: Di Luca, Daniel Garbin, et al.
Publicado: (2022)

Emerging Therapeutic Options for Chronic Pruritus
por: Reszke, Radomir, et al.
Publicado: (2020)

Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease
por: Scaria, P. Thomas, et al.
Publicado: (2009)

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
por: Verstockt, Sare, et al.
Publicado: (2021)

Targeting the PGD(2)/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives
por: Kupczyk, Maciej, et al.
Publicado: (2017)

Dose–response relationship between protein intake and muscle mass increase: a systematic review and meta-analysis of randomized controlled trials
por: Tagawa, Ryoichi, et al.
Publicado: (2020)

MicroRNA: Potential Targets for the Development of Novel Drugs?
por: Wu, Wei
Publicado: (2012)

EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise
por: Westphal, Manfred, et al.
Publicado: (2017)

Targeting Inflammation in Acne: Current Treatments and Future Prospects
por: Cruz, Sebastian, et al.
Publicado: (2023)

Kidney cachexia or protein‐energy wasting in chronic kidney disease: facts and numbers
por: Koppe, Laetitia, et al.
Publicado: (2019)

Chronic conditions in children and young people: learning from administrative data
por: Wijlaars, Linda P M M, et al.
Publicado: (2016)

Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
por: Chock, Alan, et al.
Publicado: (2012)

Modifying Phosphate Toxicity in Chronic Kidney Disease
por: Vervloet, Marc
Publicado: (2019)

Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain
por: Sisignano, Marco, et al.
Publicado: (2022)

The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
por: Gonçalves, Maria Carolina Bittencourt, et al.
Publicado: (2022)

Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline
por: Mok, Chi Chiu
Publicado: (2023)

Systematic review and meta‐analysis: Is there any role for antioxidant therapy for pain in chronic pancreatitis
por: Mohta, Srikant, et al.
Publicado: (2020)

How did the ancient bacterium, Helicobacter pylori, cause an epidemic of chronic duodenal ulceration?
por: Roberts‐Thomson, Ian C
Publicado: (2021)

Sustained Diet-Induced Remission in Pediatric Crohn’s Disease Is Associated With Kynurenine and Serotonin Pathways
por: Ghiboub, Mohammed, et al.
Publicado: (2023)

Comparison of the association intensity of creatinine and cystatin C with hyperphosphatemia and hyperparathyroidism in patients with chronic kidney disease
por: Min, Byungju, et al.
Publicado: (2023)

Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease
por: Musa-Veloso, Kathy, et al.
Publicado: (2018)

Microbiomarkers in inflammatory bowel diseases: caveats come with caviar
por: Sommer, Felix, et al.
Publicado: (2017)

COVID-19 and stroke—Understanding the relationship and adapting services. A global World Stroke Organisation perspective
por: Markus, Hugh S, et al.
Publicado: (2021)

Targeting the Serotonin 5-HT(7) Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date
por: Nikiforuk, Agnieszka
Publicado: (2015)

Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells
por: Baig, Mirza S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gj7gcjuhdro4o8ijlb3eq8u8pf